CDKN1B and cervical carcinoma: As shown in this study, HK2 overexpression could activate ERK1/2 through the Raf/MEK/ERK signaling pathway, further promoting cell proliferation and tumor formation by inducing cyclin A1 and reducing p27 expression in cervical cancer cells.